Cargando…
Precision medicine: from pharmacogenomics to pharmacoproteomics
Disease progression and drug response may vary significantly from patient to patient. Fortunately, the rapid development of high-throughput ‘omics’ technologies has allowed for the identification of potential biomarkers that may aid in the understanding of the heterogeneities in disease development...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037608/ https://www.ncbi.nlm.nih.gov/pubmed/27708556 http://dx.doi.org/10.1186/s12014-016-9127-8 |